Two new studies indicate Paxlovid's usefulness in helping prevent hospitalization, death in COVID outpatients

Paxlovid may help prevent hospitalization, death in COVID outpatients CIDRAP

Two new studies, one from the United States and one from Canada, suggest that the oral antiviral drug Paxlovid (nirmatrelvir-ritonavir) is effective in lowering the odds of hospitalization or death from the SARS-CoV-2 Omicron subvariant.

...